ArticleCurrent cancer drug targets2025

FHOD3 Promotes the Progression of Lung Cancer by Regulating the Caspase-3-Mediated Signaling Pathway.

Zhonglu Peng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.